Posted in | News | Nanomedicine

Nanovesicles to Combat Multiple Cancer Cells

Bexion Pharmaceuticals has received the Biotech Innovation Award at the Cincinnati USA Innovation Awards program hosted by the Cincinnati Business Courier, the Cincinnati USA Regional Chamber and CincyTech.

Related Stories

The award acknowledges the companies and people who turn concepts into fuel for the Tri-State (Ohio/Kentucky/Indiana) economic program.

According to Dr. Ray Takigiku, co-founder and chief executive officer of Bexion, cancer diagnosis and therapy needs more research and innovation. He also said the BXQ-350 nanovesicles being developed by his company will shift the paradigm approach to cancer treatment.

The BXQ-350 nanovesicles could help treat glioblastoma, a form of brain cancer. The devices are conducive to the membrane patches existing in various kinds of cancer cells including glioblastoma. Laboratory trials undertaken by the company has revealed that the treatment is effective in combating different kinds of cancerous cells in multiple animal tumors that were cultured in the laboratory test tubes.

Source: http://www.bexionpharma.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). Nanovesicles to Combat Multiple Cancer Cells. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=22267.

  • MLA

    Chai, Cameron. "Nanovesicles to Combat Multiple Cancer Cells". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=22267>.

  • Chicago

    Chai, Cameron. "Nanovesicles to Combat Multiple Cancer Cells". AZoNano. https://www.azonano.com/news.aspx?newsID=22267. (accessed April 19, 2024).

  • Harvard

    Chai, Cameron. 2019. Nanovesicles to Combat Multiple Cancer Cells. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=22267.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback